ArticleInternational journal of analytical chemistry2025
Pharmacokinetics Study of Herb-Drug Interaction of
Article in International journal of analytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Plant extracts and phytochemicals in canine and feline mammary cancer models: current evidence and comparative perspectives.Veterinary research communications · 2026Review
- Determination and Pharmacokinetic of Peiminine in Beagle Dogs by UPLC-MS/MS.International journal of analytical chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Based on the establishment and validation of a UPLC-MS/MS method for detecting glipizide in beagle plasma, the herb-drug interaction (HDI) between berberine and glipizide was studied. After gradient elution separation of glipizide and internal standard, multiple reaction monitoring was used for detection in positive ion mode. The ion reactions used for quantitative analysis were glipizide m/z 446.0 ⟶ 321.0 and IS m/z 307.1 ⟶ 220.0. Six beagle dogs were treated with glipizide alone and berberine intervention, and the pharmacokinetic changes of glipizide were compared. The UPLC-MS/MS method has good linearity and the advantages of being green, simple, sensitive, and fast. After continuous administration of berberine to beagle dogs for 7 days, the pharmacokinetic process of glipizide changed with
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.